The ADRB3 Receptor in Pregnancy

Suspended

• Conditions: Pregnancy Complications

• Registration Number: NCT02381106
• Lead Sponsor: Karolinska Institutet

Brief Summary

The primary overall objective of this study is to characterize the levels of and compare levels of the ADRB3 receptor in human non-pregnant myometrium, pregnant myometrium at different time points in pregnancy, in normal and dysfunctional labor and also to measure levels and expression of these receptors in placental arteries at different maturation statuses of placenta and in pre-eclampsia/hypertension

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2014-11
• Study First Submitted: 2014-11-11
• Study First Submitted QC: 2015-03-05
• Study First Posted: 2015-03-06
• Status Verified: 2023-05
• Last Update Submitted: 2023-05-15
• Last Update Posted: 2023-05-17
• Primary Completion: 2028-12
• Study Completion: 2029-12

Recruitment & Eligibility

• Status: SUSPENDED
• Sex: Female
• Target Recruitment: 80

Inclusion Criteria

• Women undergoing cesarian section

Read More

Exclusion Criteria

• Interkurrent diseases

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
characterization of the levels of the ADRB3 receptor in human pregnant myometrium	1 month

Trial Locations

Locations (1)

Dept of Obstetrics and Gynecology, Danderyd Hospital; 🇸🇪 Stockholm, Sweden